Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2011-01-31
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Subjects will be recruited from PI and Sub-I clinics and Oregon Health \& Science University (OHSU) research opportunities website.
1. Adult and Adolescent Study:
Moisturizer Intervention - There will be 2-3 visits for this study: a screening visit, a baseline visit, and a final visit. Adults with a history of eczema will be asked to apply one of four possible moisturizers to one arm and nothing to the other arm for four weeks. The moisturizers, which will be assigned to the subjects, include either Cetaphil Cream, Aveeno Eczema Therapy Moisturizing Cream, CeraVe Moisturizing Cream, or Vaseline 100% Petroleum Jelly. Subjects can use other skin treatments as needed for their skin condition, but may not treat the arms during the study. Non-invasive tests of the skin will be made at Visit 1 and after four weeks (Visit 2). The skin measurements that will be performed are:
* Transepidermal loss (TEWL)- measures how much water is lost across the skin barrier
* Skin Cohesion and TEWL - TEWL after 5, 10, 15, and 20 tape strips will measure skin barrier function after tape-stripping
* Skin electrical capacitance - measures the moisture in the top layer of skin
* Skin pH - measures the acidity of the skin
* Stratum corneum cohesion assay - tape-stripping to measure the protein removed from the top layer of skin
* Lipidomic analysis - measures the lipids, or oils, in the top layer of skin Control - There will be 1-2 visits for this group: a screening visit and baseline visit, which can be combined. Non-invasive tests of the skin will be taken and include the skin measurements that will be performed are the same as the Moisturizer Intervention group.
2. Pediatric Study: There will be 2-3 visits for this study: a screening visit, a baseline visit, and a final visit. Infants and toddlers between 3 months and 3 years of age without a history of skin barrier diseases will be assigned to a moisturizer, which include either Cetaphil Cream, Aveeno Eczema Therapy Moisturizing Cream, CeraVe Moisturizing Cream, or Aveeno Skin Relief Moisture Repair Cream. Non-invasive tests of the skin will be made at Visit 1 and after four weeks (Visit 2).
* TEWL- measures how much water is lost across the skin barrier
* Skin electrical capacitance - measures the moisture in the top layer of skin
* Skin pH - measures the acidity of the skin
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Barrier Enhancement for Eczema Prevention
NCT04680520
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
NCT00806221
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis
NCT02594969
Feasibility Study of Barrier Enhancement for Eczema Prevention
NCT01142999
Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema
NCT01326910
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pediatric Moisturizer Intervention
Apply one of four moisturizers to one arm daily for four weeks.
Pediatric Moisturizer
Apply moisturizer for four weeks daily to only one arm. Do not apply moisturizer to the other arm.
Adult Moisturizer Intervention
Apply moisturizer to one arm once a day for four weeks.
Adult Moisturizer
Apply moisturizer for four weeks daily to only one arm. Do not apply moisturizer to the other arm.
Adult Control
No intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pediatric Moisturizer
Apply moisturizer for four weeks daily to only one arm. Do not apply moisturizer to the other arm.
Adult Moisturizer
Apply moisturizer for four weeks daily to only one arm. Do not apply moisturizer to the other arm.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Overall good health
* Have a history of atopic dermatitis
* 12 years or older
* 4 x 4 cm of non-lesional skin on both inner forearms
* No other conditions that would make the use of the four emollients harmful to the subject, such as known allergy to an emollient or a component o the emollient
Exclusion Criteria
* Have an active skin infection
* Are receiving phototherapy
* Any immunodeficiency disorder or severe genetic skin disorder
* Any other serious condition that would make the use of emollients inadvisable
* Any other major medical problems that the investigator deems may increase the risk of adverse events with the intervention
2. Adult Study
* Use of topical steroids on the inner forearms or oral immunosuppressive medications for 4 weeks prior to participation in the study.
* Receiving phototherapy or systemic immunosuppressive therapy three months prior to participation in the study.
3 Months
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oregon Health and Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eric Simpson
MD, MCR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric Simpson, MD, MCR
Role: PRINCIPAL_INVESTIGATOR
Oregon Health & Science University, Department of Dermatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oregon Health & Science University Center for Health & Healing
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Emollient Evaluation Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.